MFDS Expands Use of "Manual Drug Infusion Pump"

The Ministry of Food and Drug Safety announced on March 17 that it has designated two types of medical devices, which are necessary for the diagnosis and treatment of patients with rare and intractable diseases but have no domestic alternatives, as "rare and emergency import medical devices."


Intervertebral Body Fixation Device for Pediatric Scoliosis Designated as Emergency Import Medical Device View original image

The system for rare and emergency import medical devices allows the government to directly import and supply medical devices that are not approved or distributed in Korea.


The newly designated "intervertebral body fixation device (MAGEC Spinal Bracing and Distraction System)" is a product that reduces the need for repeated surgeries in pediatric patients with scoliosis during their growth period. Recently, domestic supply was halted due to the discontinuation of production by overseas manufacturers, but the government has now established a supply system through an expedited designation process.


Additionally, as the indication for the rare drug "Empaveli Injection," used to treat paroxysmal nocturnal hemoglobinuria (PNH), has been expanded in its approval, the intended use of the dedicated self-injection medical device "manual drug infusion pump" for this medication has also been broadened.


Paroxysmal nocturnal hemoglobinuria is a disease in which red blood cells undergo hemolysis, causing patients to excrete dark cola-colored urine at night. For treatment, patients prescribed Empaveli Injection must use this manual infusion pump to self-administer the drug subcutaneously at home.



The Ministry of Food and Drug Safety stated, "With this designation, pediatric scoliosis patients will be able to spend more time at school and home, rather than undergoing repeated surgeries in the operating room," adding, "Patients with rare kidney diseases are also expected to have easier access to treatment at home."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing